Search

  • HOME
  • Search
Original Articles
A Randomized, Double-Blind Study to Assess the Efficacy and Safety of Oral LB20304 (Gemifloxacin) at Doses of 160mg or 320mg (Equivalent to 200mg or 400mg of the Mesylate Salt) Once Daily for 7 Days for the Treatment of Acute Exacerbations of Chronic Bron
Young Whan Kim, Young Soo Shim, Won Dong Kim, Tae Sun Shim, Hong Mo Kang, Byoung Whui Choi, Jae Yeol Kim, O Jung Kwon, Hojoong Kim, Ju Ock Kim, Ki Suck Jung, In Gyou Hyeon, Eun Kyung Mo, Seung Joon Lee, Gui Hyun Nam, Kye Young Lee, Jae Seuk Park
Tuberc Respir Dis. 2003;55(1):69-87.   Published online July 1, 2003
PDFPDF    

Tuberculosis and
Respiratory Diseases

Print ISSN: 1738-3536
Online ISSN: 2005-6184



ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail: katrdsubmit@lungkorea.org                

Copyright © 2024 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2PI

Close layer
prev next